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ABSTRACT
Introduction Some scaphoid fractures become visible 
on radiographs weeks after a trauma which makes 
normal radiographs directly after trauma unreliable. 
Untreated scaphoid fractures can lead to scaphoid non- 
union progressing to osteoarthritis. Therefore, the general 
treatment for patients with a clinically suspected scaphoid 
fracture and normal initial radiographs is immobilisation 
with below- elbow cast for 2 weeks. However, most 
of these patients are treated unnecessarily because 
eventually less than 10% of them are diagnosed with an 
occult scaphoid fracture. To reduce overtreatment and 
costs as a result of unnecessary cast treatment in patients 
with a clinically suspected scaphoid fracture and normal 
initial radiographs, we designed a study to compare 
below- elbow cast treatment with supportive bandage 
treatment. We hypothesise that the functional outcome 
after 3 months is not inferior in patients treated with 
supportive bandage compared to patients treated with 
below- elbow cast, but with lower costs in the supportive 
bandage group.
Methods and analysis The SUSPECT study is an open- 
labelled multicentre randomised controlled trial with 
non- inferiority design. A total of 180 adult patients with a 
clinically suspected scaphoid fracture and normal initial 
radiographs are randomised between two groups: 3 days 
of supportive bandage or 2 weeks of below- elbow cast. 
We aim to evaluate the functional outcome and cost- 
effectiveness of both treatments. The primary outcome 
is the functional outcome after 3 months, assessed with 
the Quick Disability of the Arm, Shoulder and Hand score. 
Secondary outcomes include functional outcome, recovery 
of function, pain, patient satisfaction, quality of life and 
cost- effectiveness measured by medical consumption, 
absence from work or decreased productivity.
Ethics and dissemination The Medical Ethics 
Committee of the Erasmus MC Medical Centre, Rotterdam, 
approved the study protocol (MEC-2017-504). We plan 
to present the results after completion of the study at 
(inter)national conferences and publish in general peer- 
reviewed journals.
Trial registration number NL6976.
INTRODUCTION
Up to 32% of all scaphoid fractures result 
in non- union, leading to progressive osteo-
arthritis.1 While most fractures are visible 
on radiographs directly after trauma, not all 
scaphoid fractures can be diagnosed on the 
initial radiographs. To avoid untreated occult 
scaphoid fractures, all patients with a clini-
cally suspected scaphoid fracture and normal 
initial radiographs are treated with a below- 
elbow cast until re- examination or further 
diagnostics.2 3 Finally, less than 10% of these 
patients appear to have a scaphoid fracture 
resulting in a large number of overtreatment, 
unnecessary absenteeism from work and 
increased healthcare costs.4 5
Most occult scaphoid fractures can be 
diagnosed on repeated conventional radiog-
raphy after 10–14 days.6 These occult frac-
tures are in general non- displaced fractures 
of the waist or distal pole of the scaphoid, in 
which an intact periosteal envelop provides 
stability.7 8 Known risk factors for scaphoid 
non- union are proximal fracture location, 
Strengths and limitations of this study
 ► This is the first multicentre randomised controlled 
trial to evaluate if treatment with supportive ban-
dage results in not inferior functional outcome to 
below- elbow cast in patients with a clinically sus-
pected scaphoid fracture.
 ► All patients are re- evaluated clinically and radio-
graphically after 1 year.
 ► The cost- effectiveness of the treatment up to 1 year 
is studied.
 ► The main limitation of the study is that the study 
is not blinded for participants, physicians and 
researchers.
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fracture displacement and start of treatment more than 
4 weeks after trauma.8–10 When adequate treatment for 
a scaphoid fracture is started within 4 weeks after the 
trauma, the non- union rate does not increase.8 Therefore, 
supportive bandage and re- examination within 2 weeks 
can be a good alternative treatment for patients with a 
clinically suspected scaphoid fracture with normal radio-
graphs. In 1988, one randomised study of 106 patients 
with a clinically suspected scaphoid fracture showed that 
treatment with supportive bandage compared with below- 
elbow cast in these patients decreased the immobilisation 
time and absence of work without negative consequences 
on fracture healing. However, functional outcome and 
cost- effectiveness were not evaluated, and the follow- up 
period was not clearly stated.8
We designed a pragmatic randomised controlled trial 
with 1- year follow- up to evaluate the functional outcome 
and cost- effectiveness of treatment with a supportive 
bandage compared with below- elbow cast in patients 
with a clinically suspected scaphoid fracture and normal 
initial radiographs. We hypothesise that treatment with 
supportive bandage results in a not inferior functional 
outcome compared with below- elbow cast, with lower 
costs in the supportive bandage group.
Objectives
We designed a pragmatic, multicentre randomised 
controlled trial with a non- inferiority design with two 
groups. The primary objective of this study is to deter-
mine if treatment with supportive bandage compared 
with below- elbow cast in patients with clinically suspected 
scaphoid fracture and normal initial radiographs results 
in not inferior functional outcome after 3 months, 
measured with the Quick Disability of the Arm, Shoulder 
and Hand (QDASH).
As secondary objectives, we assess whether treatment 
of patients with a clinically suspected scaphoid fracture 
with a bandage is cost- effective compared with cast. 
Cost- effectiveness is evaluated by medical consumption, 
absence from work or decreased productivity, and quality 
of life, measured in quality- adjusted life years (QALYs).
Furthermore, we assess if supportive bandage compared 
with cast results in not inferior pain, patient satisfaction 
of the received treatment, functional outcome measured 
with the QDASH, recovery of function measured with 
physical examination and the Patient- Rated Wrist/Hand 
Evaluation (PRWHE) and quality of life.
METHODS AND ANALYSIS
This manuscript is written according to the Consolidated 
Standards of Reporting Trials statement and the Standard 
Protocol Items: Recommendations for Interventional 
Trials guidelines.11 12
Patient and public involvement
In the absence of a patient association, we formed a panel 
of three patients with a (suspected) scaphoid fracture to 
think along with, and comment on our study. This panel 
of patients analysed the study (aim, burden for patient, 
willingness to participate), patient information sheet and 
how the future results should be reported to the patients. 
To improve our study, we evaluate the study procedures 
and the patient burden with participating patients during 
the recruitment period. After termination of the study, 
we present our study results to all participating patients.
Study design
The SUSPECT study is performed in nine hospitals in the 
Netherlands. All departments involved in the treatment 
of patients with a clinically suspected scaphoid fracture in 
each participating hospital participate in the study.
All patients who present with a clinically suspected 
scaphoid fracture after trauma at the emergency depart-
ment (ED), who match the inclusion and exclusion 
criteria, are informed about the study by their treating 
physician. These patients receive the participant informa-
tion sheet and are invited to ask questions about the study. 
As direct start of treatment is necessary, patients have to 
decide on study participation after the information is 
provided at the ED. Written informed consent is obtained 
from the patient prior to inclusion (online supplemental 
appendix 1). All included patients are randomised at the 
ED and allocated to treatment with supportive bandage 
or below- elbow cast.
Patients revisit the outpatient clinic after 2 weeks and 
1 year. After 2 weeks, the researcher re- examines the 
patient first. Next, radiographs with scaphoid- specific 
views are obtained (without cast or bandage around 
the wrist) according to the hospital protocol. Last, the 
physician re- examines the patient and determines the 
diagnosis, treatment and follow- up according to their 
hospital protocol without interference of the researcher. 
When a scaphoid fracture is diagnosed by the physician, 
patients are treated for a scaphoid fracture according to 
hospital protocol with either cast or surgery. After 1 year, 
the researcher re- examines the patients and wrist radio-
graphs are made.
During the follow- up period, patients receive question-
naires by email after inclusion, 2 weeks, 6 weeks, 3 months, 
6 months, 9 months and 1 year of follow- up. (figure 1)
Due to the Dutch privacy law, it is not allowed to screen 
eligible patients at the ED to detect how many eligible 
patients are not participating in our study.
Study population
All adult patients who visit the ED of the participating 
hospitals, within 48 hours after trauma, with a clinically 
suspected scaphoid fracture without a fracture on the 
radiograph, are invited to participate in the study.
Inclusion criteria
 ► Aged 18 years or older.
 ► Trauma maximum of 48 hours before.
 ► Anatomical snuff box (ASB) tenderness or scaphoid 
tubercle (ST) tenderness.
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 ► No scaphoid fracture reported by the radiologist or 
treating physician on the initial radiographs with 
scaphoid- specific views (minimally three views).
Exclusion criteria
 ► Concomitant injury of the ipsilateral extremity that 
needs treatment with movement restriction by cast or 
supportive bandage.
 ► Inability to complete study forms due to insufficient 
command of the Dutch language.
 ► A scaphoid fracture diagnosed on the initial radio-
graphs by a supervising radiologist in retrospect.
Randomisation
After written informed consent is obtained, patients are 
centrally randomised through computer- based variable 
block randomisation (2, 4, 6 blocks) by Castor Electronic 
Data Capture (EDC) to enable allocation concealment.13 
The allocation ratio is 1:1 and randomisation is stratified 
per hospital due to potential differences in applied cast 
and the number of scaphoid- specific views per hospital .
Because of practical reasons, there is no blinding of the 
treatment group for the physician, patient and researcher. 
We do perform the assessment of radiographs and statis-
tical analysis both blinded.
Interventions
Intervention group (supportive bandage)
Patients in the intervention group receive a below- elbow 
supportive bandage for 3 days at the ED. After 3 days the 
patients are allowed to remove the bandage and move 
the wrist driven by the amount of pain. When patients 
experience too much pain despite adequate analgesia, an 
additional appointment is made at the outpatient clinic 
to apply a below- elbow cast for analgesic purposes. The 
applied cast is similar to the control group, conform 
hospital protocol. The patients who cross over to cast 
remain in the study.
Control group (below-elbow cast)
The usual care in the Netherlands for patients with clini-
cally suspected scaphoid fracture at the ED is below- elbow 
Figure 1 SUSPECT study flow chart. PROMs, patient- rated outcome measures.
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cast and re- examination after 2 weeks (figure 2).2 The 
applied below- elbow cast type is according to hospital 
protocol and can be circular or splint, with or without the 
thumb included.
Outcome
We collect the following baseline variables: demographic 
data (eg, age, gender, height, weight, hand dominance), 
details about the trauma (eg, fall onto an outstretched 
hand, high- energy trauma, low- energy trauma, sports 
injury) and comorbidities such as smoking status, previous 
arm injuries and general medical history.
Primary outcome
The primary outcome is the difference in functional 
outcome between the intervention group and control 
group measured with the QDASH after 3 months of 
follow- up. We selected the QDASH as the primary 
outcome, as it takes the function of both hands into 
account. With this information, we can reflect if the wrist 
problem results in an impaired functional outcome in 
daily life.
Secondary outcomes
 ► Functional outcome measured with the QDASH 
after inclusion and at 2 weeks, 6 weeks and 1 year of 
follow- up (table 1).
 ► Recovery of function evaluated with PRWHE after 
inclusion and at 2 weeks, 6 weeks, 3 months and 1 year 
of follow- up.
 ► The amount of pain scored with the visual analogue 
scale (VAS) at rest and during movement after inclu-
sion and at 2 weeks, 6 weeks, 3 months and 1 year of 
follow- up.
 ► Patient satisfaction of the treatment is measured after 
2 weeks and 3 months of follow- up.
 ► Quality of life assessed by the 5- level EuroQol- 5D 
(EQ- 5D- 5L) after inclusion and at 2 weeks, 6 weeks, 
3 months and 1 year of follow- up. When the patient 
reports medical consumption or decreased produc-
tivity due to the wrist problems after 6 or 9 months of 
follow- up, the EQ- 5D- 5L is sent to the patients as well.
 ► To assess the costs and cost- effectiveness of both 
interventions, we collect information about medical 
consumption (eg, additional imaging and therapeutic 
hospital procedures) and productivity costs We use 
iMTA Medical Consumption Questionnaire (iMCQ) 
and iMTA Productivity Cost Questionnaire (iPCQ) 
after 6 weeks, 3 months, 6 months, 9 months and 1 
Figure 2 Treatment of intervention and control groups.
Table 1 Description of patient- rated outcome measures and examinations per follow- up moment
After 
Inclusion 2 weeks 6 weeks 3 months 6 months 9 months 1 year
Radiograph Scaphoid Scaphoid         Wrist
Physical 
examination
x x         x
PROM QDASH
PRWHE
VAS
EQ- 5D- 5L
QDASH
PRWHE
VAS
Patient 
satisfaction
EQ- 5D- 5L
QDASH
PRWHE
VAS
EQ- 5D- 5L 
iMCQ
iPCQ
QDASH
PRWHE
VAS
Patient 
satisfaction
EQ- 5D- 5L 
iMCQ
iPCQ
iMCQ iPCQ
(EQ- 5D- 5L)
iMCQ iPCQ
(EQ- 5D- 5L)
QDASH
PRWHE
VAS
EQ- 5D- 5L 
iMCQ
iPCQ
EQ- 5D- 5L, 5- level EuroQol- 5D; iMCQ, iMTA Medical Consumption Questionnaire; iPCQ, iMTA Productivity Cost Questionnaire; PROM, 
patient- rated outcome measure; PRWHE, Patient- Rated Wrist/Hand Evaluation; QDASH, Quick Disability of the Arm, Shoulder and Hand; 
VAS, Visual Analogue Scale Pain at rest and during movement.
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year of follow- up (table 1) and we screen the elec-
tronic patient status.
 ► Physical examination is performed at inclusion, after 
2 weeks and 1 year of follow- up. At inclusion, the 
physical examination is performed by the treating 
physician. They register if the patient has tenderness 
ASB, tenderness ST, compression pain thumb, radial 
sided wrist pain with resisted supination and radial 
sided wrist pain with ulnar deviation. A previous 
study showed that these clinical tests have the highest 
sensitivity for a scaphoid fracture.14 After 2 weeks 
and 1 year, the function of the wrist is assessed by 
the researcher. The physical examination includes 
the above- mentioned clinical tests and swelling or 
haematoma on the radial side of the wrist. Range of 
motion of the wrist (palmar flexion, dorsal flexion, 
ulnar deviation, radial deviation, supination and 
pronation) and finger- to- palm distance are meas-
ured with a goniometer. The finger- to- palm distance 
is the distance from the tip of the finger to the distal 
palmar crease, when the fingers are in maximal active 
flexion.15 We assess the opposition of the thumb with 
the Kapandji score.16 The Kapandji score ranges 
from 0 to 10, where 0 indicates no opposition and 10 
maximal opposition. Grip strength is measured with 
a hand dynamometer (Jamar hand dynamometer), 
and is defined as the maximum grip strength after 
three attempts. Range of motion and grip strength of 
both wrists are examined. One year after inclusion, 
we additionally test the scapholunate (SL) ligament 
by identifying tenderness over the dorsal SL interval, 
performing the finger extension test and the Watson 
test (table 2). The finger extension test is positive 
when resisted extension of the fingers with the wrist 
in flexion is painful.17 To perform the Watson test, 
the patients’ wrist is in slight dorsal flexion and ulnar 
deviation, with the researchers’ thumb on ST and 
fingers wrapped around the distal radius. Then, the 
researcher moves the patients’ wrist radially and in 
palmar flexion. The Watson test is positive if a painful 
clunk is noticed.17 18
 ► Radiographic re- examination is performed after 2 
weeks and 1 year of follow- up. After 2 weeks, the radi-
ographs include scaphoid- specific views (minimally 
three views) to identify a scaphoid fracture. After 
1 year, a posterior- anterior and lateral wrist radio-
graphs are made to determine the presence of any 
post- traumatic injuries (eg, scaphoid non- union, SL 
dissociation). The radiographs are evaluated by two 
independent assessors.
 ► Detailed information about the received treatment 
is reported. We address the number of patients who 
cross over from their allocated treatment, days of 
cast or supportive bandage before the outpatient 
department appointment and applied treatment 
after the outpatient department appointment (cast 
or surgery).
 ► (Serious) adverse events are noted, such as scaphoid 
fracture and scaphoid non- union. (Detailed informa-
tion can be found at safety considerations.)
 ► Other diagnoses are reported such as other carpal 
fractures or ligament injuries.
Instruments
Functional outcome is measured with the mandatory 
module of the QDASH. The QDASH is the short version 
of the DASH and consists of 11 questions about symptoms 
and physical function of both arms during the last week. 
Each question can be scored from 1 to 5. The total score 
ranges from 0 - 100 (high score indicates severe disability 
of the upper extremity) The Dutch QDASH has shown 
good validity, reliability and responsiveness for compa-
rable patients.19 20
The PRWHE questionnaire evaluates the painful wrist 
during the last week. The questionnaire consists of 
three subscales about pain, function and cosmetics. The 
cosmetic field is not included in the score. The pain and 
function subscales consist each of 15 questions that can be 
scored from 0 to 10. The total PRWHE score ranges from 
0 - 100 (high score indicates severe pain and impaired 
function of the painful wrist). The Dutch PRWHE has 
shown good validity, reliability and responsiveness for 
comparable patients.20
Pain scores at rest and during movement are examined 
with the VAS for pain with a range from 0 - 10. A high VAS 
score indicates severe pain. The VAS for pain is widely 
used in research with comparable patients.21
Patient satisfaction is assessed by the questions ‘how 
satisfied are you with the treatment’, ‘would you prefer the 
other treatment at the ED under similar circumstances?’ 
Table 2 Physical examination per follow- up moment
At 
Inclusion 2 weeks 1 year
Swelling radial side wrist   x x
Haematoma radial side wrist   x x
Tenderness ASB x x x
Tenderness ST x x x
Compression pain thumb x x x
Painful resisted supination x x x
Painful UD x x x
SL ligament     x
Kapandji score   x x
Range of motion   x x
Finger- to- palm distance   x x
Grip strength   x x
Range of motion includes palmar flexion, dorsal flexion, ulnar 
deviation, radial deviation, supination and pronation.
ASB, anatomical snuff box; SL, scapholunate ligament 
examinations which consist of tenderness SL interval, finger 
extension test and Watson test; ST, scaphoid tubercle; UD, ulnar 
deviation.
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and ‘if yes, why?’. The first question can be scored on a 
VAS scale 0 to 10. A high score indicates satisfaction.
Quality of life is measured with the EQ- 5D- 5L. This ques-
tionnaire consists of five questions and a VAS. The ques-
tions are about mobility, self- care, usual activities, pain 
or discomfort and anxiety or depression. Each question 
can be scored as: no problem, slight problem, moderate 
problem, severe problem and extreme problem. The 
index score ranges from 0 (death) to 1 (perfect health). 
Health is reported on a VAS from 0 to 100. A high score 
indicates better health state. The EQ- 5D- 5L is recom-
mended for the assessment of quality of life in trauma 
patients, especially for economic assessments.22
To assess the costs and cost- effectiveness of the inter-
vention with the usual care we include the Medical 
Consumption Questionnaire (iMCQ) and Productivity 
Cost Questionnaire (iPCQ). The iMCQ measures the 
total medical consumption by measuring the use of diag-
nostics, consultations, ED visits, physical therapy, medi-
cation and aids. The iPCQ measures productivity costs. 
This questionnaire evaluates costs of absence of work and 
decreased productivity at paid or unpaid work. The iMCQ 
and iPCQ are short generic measurement instruments.23
Sample size
Our hypothesis is that patients with a clinically suspected 
scaphoid fracture with normal initial radiographs treated 
with a supportive bandage have no inferior functional 
outcome after 3 months compared with below- elbow cast, 
but with lower costs. The power calculation is based on 
the proof of non- inferiority. We took 50% of the margin 
of clinical minimal important difference of QDASH.24 
This resulted in a margin of non- inferiority of 7.50 points 
on the QDASH. The SD of QDASH after 3 months has 
been reported to be 14.25 We used a power of 90% and 
a one- sided alpha of 0.025. To detect non- inferiority of 
supportive bandage compared with below- elbow cast 148 
patients are needed (74 patients per group). Accounting 
for a 15% lost to follow- up, a total of 180 patients are 
required. When the lost to follow- up or change of allo-
cated treatment is higher than 15%, we will include more 
patients to have 74 patients per group to answer our 
primary research question. When the patient recruitment 
rate at the ED is behind our expectations, we invite more 
hospitals to participate.
Data collection
We collect data by electronic data capture with Castor 
EDC.13 Paper- based case report forms are used at the ED 
and the outpatient department. The researcher inserts 
these data in Castor EDC. Questionnaires are sent directly 
to the patients through email via Castor EDC. In case an 
email address is not available, a paper case report form is 
sent to the patient. When the patient does not respond, 
we will contact the patient by telephone.
We screen the electronic patient status to collect infor-
mation about (serious) adverse events, hospital visits, 
additional imaging and treatment for the wrist injury 
during the follow- up period of the study.
Data analysis
We perform all analyses blinded for treatment allocation. 
The distribution analysis of baseline variables is tested by 
the Shapiro- Wilk test. For normally distributed variables, 
parametric tests are used. For those variables that are not 
normally distributed, non- parametric tests are used. We 
report the proportion of diagnosis and adverse events per 
allocated treatment group.
All outcomes are analysed ‘by intention to treat anal-
ysis’ with a linear mixed model with specified fixed and 
random effects. The covariance structure is unstructured. 
Restricted maximum likelihood will be used to estimate 
parameters. The assumptions of our model (linearity, 
homoscedasticity and normal distribution of the error 
terms) are tested. Should any of these assumptions seri-
ously fail, variable transformations are used.
For our primary outcome, QDASH at 3 months, and 
secondary outcomes PRWHE, VAS score, EQ- 5D- 5L 
measurement time is a fixed effect and we add an inter-
action term of measurement time by treatment. Hospital 
is a random intercept and to analyse repeated measure-
ments, we add a random intercept for patients (nested 
with hospital). The data after inclusion, and after 2 
weeks, 6 weeks and 3 months of follow- up are included 
in our model as repeated measures. We perform post 
hoc analyses to compare estimated means at 3 months. 
All outcomes are assessed for non- inferiority, expect cost- 
effectiveness which is assessed for superiority. A margin of 
non- inferiority of 7.50 is used for our primary outcome in 
the analyses. Since our groups are small, it can be that the 
baseline characteristics are not in balance between the 
two groups. Therefore, we add the potential confounders 
as age, gender and presence of comorbidities that influ-
ence the function of the arms, as fixed effects. We perform 
additional as- treated analysis to analyse outcomes between 
patients who received only supportive bandage until the 
outpatient department appointment after 2 weeks and 
patients who received cast in the first 2 weeks (received 
cast at the ED or crossover from bandage). Patients are 
included in our mixed models when they responded to 
the outcome questionnaire irrespective of the number of 
time points. If no data of the outcome questionnaire are 
available, we report the reasons in detail in our paper and 
discuss the potential bias. When one or more (but not 
all) of the measurements are missing, a sensitivity analysis 
is performed to clarify if the missing data are at random.
Furthermore, we assess the progress of the QDASH, 
PRWHE, VAS, EQ- 5D- 5L and physical examination 
during the 1- year follow- up. The random and fixed effects 
remain similar, only all follow- up moments are included 
in the repeated measurements.
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Cost-effectiveness analysis
General considerations
We assess the cost- effectiveness of 3 days of supportive 
bandage versus 2 weeks of below- elbow cast over a period 
of 1 year. To answer this question, we perform a cost- 
utility analysis to estimate the incremental cost per QALY 
gained, to be able to compare our study with other studies 
in musculoskeletal disorders and in other disease cate-
gories. We impute missing data by multiple imputation, 
using the pattern mixture model. Using non- parametric 
bootstrapping (randomly drawing 5000 observations 
with replacement from the patient sample), the degree 
of uncertainty for costs and health effects and the cost- 
utility ratio are depicted in a cost- effectiveness plane. In 
addition, an acceptability curve is drawn, which indicates 
the probability that the intervention studied has lower 
incremental costs per QALY gained than various thresh-
olds (dependent on disease severity) for the maximum 
willingness to pay for an extra QALY.
Cost analysis
The economic analysis is based on the societal perspec-
tive, and on the healthcare perspective in which the 
direct medical and productivity costs between the groups 
are compared. To measure the direct costs, an inventory 
of patients’ total medical consumption is made using 
the electronic patient status and the iMCQ. The use of 
diagnostics (additional radiographs, CT, MRI, ultrasound 
or bone scintigraphy), consultations, ED visits, physical 
therapy, medication and aids are evaluated. Productivity 
costs are measured with the iPCQ. Costs of absence of 
work and decreased productivity at a paid job or at 
unpaid work are evaluated. The friction cost method is 
used to calculate the productivity costs according to the 
recent Dutch guidelines. The costs per unit of medical 
consumption are estimated, using information from the 
most recent Dutch Manual for economic evaluation of 
healthcare. Costs are reported for the year 2019.
Cost-utility analysis
Patient outcomes relevant for the cost- effectiveness anal-
ysis are the number of QALYs during 1 year. Patient 
scores on the EQ- 5D- 5L version are converted into utility 
values, using the valuation algorithm of the Dutch general 
population.
Budget impact analysis
Guidelines of the ISPOR Task Force are used for the 
budget impact analysis (BIA). Relevant features and 
tariffs of the Dutch healthcare system, anticipated uptake 
of the new intervention as well as usual care are taken into 
account. The size and the eligibility of the population, 
cost of diagnostics, treatment modalities and changes 
expected in condition- related costs are considered in the 
BIA. Sensitivity analyses are performed using divergent 
scenarios from the viewpoint of the decision- makers.
The budget impact per year of implementing the new 
intervention is estimated. All elements of medical costs 
for the new intervention as well as for usual care that are 
paid by third- party payers are considered and calculated.
ETHICS AND DISSEMINATION
Safety considerations
The study compares treatment of below- elbow cast (stan-
dard treatment) with supportive bandage (intervention). 
Since the study is labelled as low risk, a data safety moni-
toring board is not required. The study is monitored at 
least once a year and the progress of the trial is reported 
once a year to the accredited Medical Review Ethics 
Committee (MEC). Adverse events are recorded by the 
researcher during follow- up. A serious adverse event is 
reported ( www. toetsingonline. nl) within a maximum of 
15 days after the researcher is notified.
Adverse events are defined as:
 ► Cast- related problems.
 ► Bandage- related problems.
 ► Loss of function.
 ► Complex regional pain syndrome.
 ► Persisting pain after 6 weeks.
Serious adverse events related to our study are defined 
as:
 ► Surgically treated scaphoid fracture.
 ► Compartment syndrome.
 ► Scaphoid non- union (scaphoid fracture without signs 
of healing after minimally 12 weeks).
Because of the multicentre study design, clinical trial 
site agreements are obtained between the initiating and 
the participating hospitals. These agreements include 
liability and insurance aspects. The patient information 
sheet reports on participants’ insurance and potential 
complications as a result of participation in the study. 
Withdrawal from the study is always possible for included 
patients without any consequences.
Ethics
The study is approved by the MEC of the Erasmus Medical 
Centrum, Rotterdam, the Netherlands (MEC-2017-504). 
All amendments are notified to the MEC and changes to 
the study are made after a favourable opinion of the MEC.
The study is conducted according to the principles of 
the Declaration of Helsinki (64th version, date: October 
2013) and in accordance with the Medical Research 
Involving Human Subjects Act (WMO) and other guide-
lines, regulations and acts.
The study is registered in the Dutch Clinical Trials 
Registry ( www. trialregister. nl). Participating patients and 
physicians are not paid for participation in the study.
Data management
Personal data of the participating patients that we collect 
during the study are changed to a study number. This 
study number is used for all study documentation, study 
reports and publications.
Data are collected with Castor EDC. Paper case report 
forms are entered in Castor EDC by the researcher. The 
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paper case report forms are securely filed in the hospital. 
All data are stored for 15 years. The final trial data set is 
accessible for the research team.
Dissemination
After completion of the study, we plan to present the 
results at (inter)national congresses and submit the 
manuscript to general peer- review journals.
Authorship is according to the International Committee 
of Medical Journal Editors guidelines and a SUSPECT 
study group is made.
Trial status
We are currently recruiting patients for the study while 
submitting the manuscript (14-01-2020). The date of first 
enrolment was 7 June 2018.
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